 THE COMPARATIVE STUDY ON RH-ENDOSTATIN ENDOSTAR CONTINUOUS INTRAVENOUS INFUSION AND ROUTINE I.V IN COMBINATION WITH GP REGIMENS FOR PHASE III BIV SQUAMOUS CELL LUNG CANCER AND BIOLOGICAL MARKERS EXPLORATION.: 